Natalie Garzorz-Stark, Dermagnostix - Leading Molecular Diagnostics for Dermatology | LSI Europe '24

Biologics and small-molecule inhibitors have created an unprecedented potential for precision medicine. Yet, diagnostics have not kept pace. Dermagnostix offers molecular diagnostic solutions to meet the need for personalized care.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Natalie Garzorz-Stark
Natalie Garzorz-Stark
CEO, Dermagnostix